Stay updated with breaking news from Patient Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- ProductLife Group (PLG), the specialised global provider of regulatory, scientific, vigilance, quality and digital transformation consulting...
Niraparib and abiraterone acetate (Akeega; Janssen Pharmaceutical Companies of Johnson & Johnson) is the first-and-only dual action tablet that combines a PARP inhibitor with abiraterone acetate administered with prednisone.
The FDA has approved FoundationOne CDx to be utilized as a companion diagnostic for the dual-action tablet of niraparib plus abiraterone acetate, which was approved for use in combination with prednisone in adult patients with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.
Atrium Health Levine Children’s Hospital is set to open its new pediatric outpatient treatment center.
Insurance companies and pbm's is sky rocketing. >> reporter: that's because insurers don't always pass on the savings according to consumers. >> that's why we called for an end to the rebate system. it's driving up the price of insulin. it's also reducing the choices people have. >> i have been rationing my insulin for three year. >> reporter: with no health insurance, champion has been taking fraction of her recommended dose a practice that's all too common. >> no one should go without i.n.s. tkeupb. it is very dangerous to ration insulin. >> reporter: pharmaceutical companies want to help. >...